Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leisha A Emens

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Biorxiv : the Preprint Server for Biology|January 8, 2024
Spatial and Compositional Biomarkers in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast CancerHaoyang Mi, Ravi Varadhan, Ashley M Cimino-Mathews, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2024
Spatial Architecture of Single-Cell and Vasculature in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast CancerHaoyang Mi, Ravi Varadhan, Ashley M Cimino-Mathews, et al.
Journal for Immunotherapy of Cancer|June 23, 2025
SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug developmentLeisha A Emens, Christine Moussion, Patrick Hwu, et al.
Seminars in Oncology|August 31, 2015
Antagonists of PD-1 and PD-L1 in Cancer TreatmentEvan J Lipson, Patrick M Forde, Hans-Joerg Hammers, et al.
Oncoimmunology|January 18, 2021
Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigenZoila A Lopez-Bujanda, Matthew G Chaimowitz, Todd D Armstrong, et al.
Human Pathology|August 7, 2013
A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathwayAshley Cimino-Mathews, Jessica L Hicks, Rajni Sharma, et al.
Journal for Immunotherapy of Cancer|October 25, 2019
Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumabLuciana Molinero, Yijin Li, Ching-Wei Chang, et al.
Current Oncology (Toronto, Ont.)|July 21, 2021
Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical PracticeJoyce O'Shaughnessy, Leisha A Emens, Stephen Y Chui, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 16, 2016
The immune microenvironment of breast ductal carcinoma in situElizabeth Thompson, Janis M Taube, Hillary Elwood, et al.
Breast (Edinburgh, Scotland)|December 22, 2022
Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysisFausto Petrelli, Valentina Bertaglia, Maria Chiara Parati, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|January 8, 2024
Spatial and Compositional Biomarkers in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast CancerHaoyang Mi, Ravi Varadhan, Ashley M Cimino-Mathews, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2024
Spatial Architecture of Single-Cell and Vasculature in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast CancerHaoyang Mi, Ravi Varadhan, Ashley M Cimino-Mathews, et al.
Journal for Immunotherapy of Cancer|June 23, 2025
SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug developmentLeisha A Emens, Christine Moussion, Patrick Hwu, et al.
Seminars in Oncology|August 31, 2015
Antagonists of PD-1 and PD-L1 in Cancer TreatmentEvan J Lipson, Patrick M Forde, Hans-Joerg Hammers, et al.
Oncoimmunology|January 18, 2021
Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigenZoila A Lopez-Bujanda, Matthew G Chaimowitz, Todd D Armstrong, et al.
Human Pathology|August 7, 2013
A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathwayAshley Cimino-Mathews, Jessica L Hicks, Rajni Sharma, et al.
Journal for Immunotherapy of Cancer|October 25, 2019
Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumabLuciana Molinero, Yijin Li, Ching-Wei Chang, et al.
Current Oncology (Toronto, Ont.)|July 21, 2021
Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical PracticeJoyce O'Shaughnessy, Leisha A Emens, Stephen Y Chui, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 16, 2016
The immune microenvironment of breast ductal carcinoma in situElizabeth Thompson, Janis M Taube, Hillary Elwood, et al.
Breast (Edinburgh, Scotland)|December 22, 2022
Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysisFausto Petrelli, Valentina Bertaglia, Maria Chiara Parati, et al.
Pageof 12